National Vaccine And Serum Institute, China

This early-stage study tested a new COVID-19 vaccine (GEN2) in 234 healthy adults aged 18 and older. The main goal was to check if the vaccine is safe and how well it triggers an immune response. Participants received one of three vaccine doses or a placebo, and researchers monit…

This study tested a vaccine to protect children aged 6 months to 13 years from norovirus, a common cause of severe vomiting and diarrhea. About 8,000 healthy kids received either the vaccine or a placebo. The goal was to see if the vaccine could prevent moderate to severe stomach…

This study tested a new COVID-19 vaccine made with CHO cells in 3,100 healthy people aged 3 and older. The goal was to see if the vaccine is safe and triggers a strong immune response. Participants received either the vaccine or a placebo in two doses. The trial is now complete.